group_id,max_val,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_00032,0.2101333955089885,FUN_000238-T1,Peve_00033352,Pocillopora_meandrina_HIv1___RNAseq.g28954.t1,three_way,62.998666666666665,FUN_000238-T1,Q5ZI58,,,,,35.3,552.0,1e-61,239.6,sp|Q5ZI58|ATOSA_CHICK Atos homolog protein A OS=Gallus gallus OX=9031 GN=ATOSA PE=2 SV=2,,,,,,
OG_00078,0.2638525240572098,FUN_000403-T1,Peve_00033519,Pocillopora_meandrina_HIv1___RNAseq.g2544.t1,three_way,79.21583333333334,FUN_000403-T1,A0A0G2K2P5,ZO1_RAT,,Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1),Rattus norvegicus (Rat),28.2,1783.0,6.4e-140,500.7,sp|A0A0G2K2P5|ZO1_RAT Tight junction protein ZO-1 OS=Rattus norvegicus OX=10116 GN=Tjp1 PE=1 SV=1,GO:0001825; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0005921; GO:0005923; GO:0007605; GO:0008013; GO:0008284; GO:0009410; GO:0009986; GO:0014704; GO:0016020; GO:0016301; GO:0016323; GO:0016324; GO:0016327; GO:0019904; GO:0030036; GO:0030054; GO:0030335; GO:0031032; GO:0031410; GO:0032496; GO:0032991; GO:0034334; GO:0036305; GO:0043066; GO:0043116; GO:0043296; GO:0044325; GO:0045177; GO:0045216; GO:0045471; GO:0046581; GO:0050839; GO:0051493; GO:0051497; GO:0070160; GO:0070830; GO:0071000; GO:0071253; GO:0071277; GO:0071333; GO:0071896; GO:0090557; GO:0098609; GO:0150105; GO:1901888; GO:1902396; GO:1903672; GO:1905605; GO:2000049; GO:2000810,actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; adherens junction maintenance [GO:0034334]; ameloblast differentiation [GO:0036305]; bicellular tight junction assembly [GO:0070830]; blastocyst formation [GO:0001825]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular response to calcium ion [GO:0071277]; cellular response to glucose stimulus [GO:0071333]; establishment of endothelial intestinal barrier [GO:0090557]; negative regulation of apoptotic process [GO:0043066]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to adherens junction [GO:0071896]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell-cell junction [GO:0150105]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cell junction assembly [GO:1901888]; regulation of cytoskeleton organization [GO:0051493]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to magnetism [GO:0071000]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605],adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; gap junction [GO:0005921]; intercalated disc [GO:0014704]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160],ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; cell adhesion molecule binding [GO:0050839]; connexin binding [GO:0071253]; kinase activity [GO:0016301]; protein domain specific binding [GO:0019904]; transmembrane transporter binding [GO:0044325],GO:0003013; GO:0003824; GO:0005634; GO:0005886; GO:0007010; GO:0007155; GO:0016740; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0050877,circulatory system process; catalytic activity; nucleus; plasma membrane; cytoskeleton organization; cell adhesion; transferase activity; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; nervous system process
OG_00092,0.3775662634329886,FUN_000466-T1,Peve_00005613,Pocillopora_meandrina_HIv1___TS.g4928.t1,three_way,56.57183333333334,FUN_000466-T1,Q9UPX8,SHAN2_HUMAN,,SH3 and multiple ankyrin repeat domains protein 2 (Shank2) (Cortactin-binding protein 1) (CortBP1) (Proline-rich synapse-associated protein 1),Homo sapiens (Human),34.1,695.0,4.9e-100,368.2,sp|Q9UPX8|SHAN2_HUMAN SH3 and multiple ankyrin repeat domains protein 2 OS=Homo sapiens OX=9606 GN=SHANK2 PE=1 SV=4,GO:0001750; GO:0001917; GO:0005829; GO:0005886; GO:0007416; GO:0007612; GO:0008284; GO:0014069; GO:0016324; GO:0017124; GO:0030160; GO:0030426; GO:0030534; GO:0031526; GO:0035176; GO:0035255; GO:0035331; GO:0043005; GO:0043025; GO:0043197; GO:0060170; GO:0060291; GO:0060292; GO:0071625,adult behavior [GO:0030534]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; negative regulation of hippo signaling [GO:0035331]; positive regulation of cell population proliferation [GO:0008284]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ionotropic glutamate receptor binding [GO:0035255]; SH3 domain binding [GO:0017124]; synaptic receptor adaptor activity [GO:0030160],GO:0005829; GO:0005886; GO:0034330; GO:0043226; GO:0050877; GO:0060090,cytosol; plasma membrane; cell junction organization; organelle; nervous system process; molecular adaptor activity
OG_00092,0.3775662634329886,FUN_000466-T1,Peve_00005613,Pocillopora_meandrina_HIv1___TS.g4928.t1,three_way,56.57183333333334,FUN_000466-T1,Q9UPX8,SHAN2_HUMAN,,SH3 and multiple ankyrin repeat domains protein 2 (Shank2) (Cortactin-binding protein 1) (CortBP1) (Proline-rich synapse-associated protein 1),Homo sapiens (Human),47.9,71.0,4.6e-13,79.3,sp|Q9UPX8|SHAN2_HUMAN SH3 and multiple ankyrin repeat domains protein 2 OS=Homo sapiens OX=9606 GN=SHANK2 PE=1 SV=4,GO:0001750; GO:0001917; GO:0005829; GO:0005886; GO:0007416; GO:0007612; GO:0008284; GO:0014069; GO:0016324; GO:0017124; GO:0030160; GO:0030426; GO:0030534; GO:0031526; GO:0035176; GO:0035255; GO:0035331; GO:0043005; GO:0043025; GO:0043197; GO:0060170; GO:0060291; GO:0060292; GO:0071625,adult behavior [GO:0030534]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; negative regulation of hippo signaling [GO:0035331]; positive regulation of cell population proliferation [GO:0008284]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ionotropic glutamate receptor binding [GO:0035255]; SH3 domain binding [GO:0017124]; synaptic receptor adaptor activity [GO:0030160],GO:0005829; GO:0005886; GO:0034330; GO:0043226; GO:0050877; GO:0060090,cytosol; plasma membrane; cell junction organization; organelle; nervous system process; molecular adaptor activity
OG_00110,0.2074262214486835,FUN_000502-T1,Peve_00043829,Pocillopora_meandrina_HIv1___RNAseq.g2405.t1,three_way,90.132,FUN_000502-T1,Q13557,,,,,65.7,478.0,3.1000000000000007e-180,632.9,sp|Q13557|KCC2D_HUMAN Calcium/calmodulin-dependent protein kinase type II subunit delta OS=Homo sapiens OX=9606 GN=CAMK2D PE=1 SV=3,,,,,,
OG_00338,0.4317060515633772,FUN_001160-T1,Peve_00043472,Pocillopora_meandrina_HIv1___RNAseq.g29219.t1,three_way,80.853,FUN_001160-T1,P50416,CPT1A_HUMAN,,"Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) (Succinyltransferase CPT1A) (EC 2.3.1.-)",Homo sapiens (Human),40.4,798.0,1.7e-154,548.1,"sp|P50416|CPT1A_HUMAN Carnitine O-palmitoyltransferase 1, liver isoform OS=Homo sapiens OX=9606 GN=CPT1A PE=1 SV=2",GO:0001666; GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0006853; GO:0007584; GO:0009410; GO:0009437; GO:0010883; GO:0016020; GO:0030674; GO:0030855; GO:0032000; GO:0042755; GO:0042802; GO:0043279; GO:0045089; GO:0045471; GO:0046222; GO:0050796; GO:0071398; GO:0097421; GO:1904772,aflatoxin metabolic process [GO:0046222]; carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of innate immune response [GO:0045089]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; response to alkaloid [GO:0043279]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641],membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674],GO:0003824; GO:0005739; GO:0005975; GO:0006575; GO:0006629; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0055085; GO:0060090,catalytic activity; mitochondrion; carbohydrate metabolic process; modified amino acid metabolic process; lipid metabolic process; transferase activity; cell differentiation; organelle; anatomical structure development; transmembrane transport; molecular adaptor activity
OG_00533,0.2570606480321201,FUN_001547-T1,Peve_00020470,Pocillopora_meandrina_HIv1___RNAseq.g2064.t1,three_way,91.406,FUN_001547-T1,E9Q8T7,DYH1_MOUSE,,Dynein axonemal heavy chain 1 (Axonemal beta dynein heavy chain 1) (Ciliary dynein heavy chain 1) (mDHC7),Mus musculus (Mouse),64.2,4208.0,0.0,5480.6,sp|E9Q8T7|DYH1_MOUSE Dynein axonemal heavy chain 1 OS=Mus musculus OX=10090 GN=Dnah1 PE=1 SV=1,GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005874; GO:0007288; GO:0008569; GO:0030317; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060294,cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; sperm axoneme assembly [GO:0007288],extracellular region [GO:0005576]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126],ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005576; GO:0005929; GO:0007010; GO:0007018; GO:0016853; GO:0022414; GO:0043226; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; extracellular region; cilium; cytoskeleton organization; microtubule-based movement; isomerase activity; reproductive process; organelle; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_00776,0.1811030909017341,FUN_003849-T2,Peve_00018009,Pocillopora_meandrina_HIv1___RNAseq.g16676.t1,three_way,81.325,FUN_003849-T2,Q8R1A4,DOCK7_MOUSE,,Dedicator of cytokinesis protein 7 (Protein moonlight),Mus musculus (Mouse),52.9,2155.0,0.0,2026.1,sp|Q8R1A4|DOCK7_MOUSE Dedicator of cytokinesis protein 7 OS=Mus musculus OX=10090 GN=Dock7 PE=1 SV=3,GO:0002244; GO:0005085; GO:0007264; GO:0022027; GO:0030424; GO:0031267; GO:0031594; GO:0043473; GO:0050767; GO:0098698; GO:0120163,hematopoietic progenitor cell differentiation [GO:0002244]; interkinetic nuclear migration [GO:0022027]; negative regulation of cold-induced thermogenesis [GO:0120163]; pigmentation [GO:0043473]; postsynaptic specialization assembly [GO:0098698]; regulation of neurogenesis [GO:0050767]; small GTPase-mediated signal transduction [GO:0007264],axon [GO:0030424]; neuromuscular junction [GO:0031594],guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267],GO:0030154; GO:0098772,cell differentiation; molecular function regulator activity
OG_00973,0.1602060876529822,FUN_004347-T1,Peve_00016492,Pocillopora_meandrina_HIv1___RNAseq.g16897.t1,three_way,84.23366666666666,FUN_004347-T1,Q1JPJ8,,,,,63.9,538.0,1.2e-207,724.2,sp|Q1JPJ8|THOP1_BOVIN Thimet oligopeptidase OS=Bos taurus OX=9913 GN=THOP1 PE=2 SV=3,,,,,,
OG_01058,0.1805422107515905,FUN_004511-T1,Peve_00012956,Pocillopora_meandrina_HIv1___RNAseq.g11643.t1,three_way,75.28316666666667,FUN_004511-T1,P48025,KSYK_MOUSE,,Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase),Mus musculus (Mouse),38.4,688.0,7.699999999999999e-116,419.5,sp|P48025|KSYK_MOUSE Tyrosine-protein kinase SYK OS=Mus musculus OX=10090 GN=Syk PE=1 SV=2,GO:0001525; GO:0001775; GO:0001784; GO:0001819; GO:0001820; GO:0001945; GO:0002092; GO:0002223; GO:0002250; GO:0002281; GO:0002283; GO:0002366; GO:0002554; GO:0002752; GO:0004674; GO:0004713; GO:0004715; GO:0005178; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006606; GO:0007159; GO:0007166; GO:0007167; GO:0007186; GO:0007229; GO:0010543; GO:0010803; GO:0016170; GO:0018108; GO:0019370; GO:0019722; GO:0019815; GO:0019901; GO:0019902; GO:0030183; GO:0030593; GO:0031334; GO:0031623; GO:0032009; GO:0032481; GO:0032725; GO:0032733; GO:0032735; GO:0032752; GO:0032753; GO:0032755; GO:0032757; GO:0032760; GO:0032765; GO:0032928; GO:0032930; GO:0032991; GO:0033630; GO:0035325; GO:0035556; GO:0038063; GO:0038156; GO:0042101; GO:0042169; GO:0042492; GO:0042742; GO:0043274; GO:0043303; GO:0043306; GO:0043313; GO:0043366; GO:0043410; GO:0045087; GO:0045579; GO:0045588; GO:0045780; GO:0046638; GO:0046641; GO:0048514; GO:0050764; GO:0050850; GO:0050853; GO:0051649; GO:0070372; GO:0071226; GO:0071396; GO:0071404; GO:0071639; GO:0090237; GO:0090330; GO:0097110; GO:0097190; GO:0097242; GO:0120162; GO:1904263; GO:1904646; GO:1990858,adaptive immune response [GO:0002250]; amyloid-beta clearance [GO:0097242]; angiogenesis [GO:0001525]; apoptotic signaling pathway [GO:0097190]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; beta selection [GO:0043366]; blood vessel morphogenesis [GO:0048514]; calcium-mediated signaling [GO:0019722]; cell activation [GO:0001775]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amyloid-beta [GO:1904646]; cellular response to lectin [GO:1990858]; cellular response to lipid [GO:0071396]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to molecule of fungal origin [GO:0071226]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; defense response to bacterium [GO:0042742]; enzyme-linked receptor protein signaling pathway [GO:0007167]; establishment of localization in cell [GO:0051649]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-delta T cell differentiation [GO:0042492]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; interleukin-3-mediated signaling pathway [GO:0038156]; intracellular signal transduction [GO:0035556]; leukocyte activation involved in immune response [GO:0002366]; leukocyte cell-cell adhesion [GO:0007159]; leukotriene biosynthetic process [GO:0019370]; lymph vessel development [GO:0001945]; macrophage activation involved in immune response [GO:0002281]; mast cell degranulation [GO:0043303]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of bone resorption [GO:0045780]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytokine production [GO:0001819]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-3 production [GO:0032752]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of receptor internalization [GO:0002092]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon production [GO:0032481]; protein import into nucleus [GO:0006606]; receptor internalization [GO:0031623]; regulation of arachidonate secretion [GO:0090237]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neutrophil degranulation [GO:0043313]; regulation of phagocytosis [GO:0050764]; regulation of platelet activation [GO:0010543]; regulation of platelet aggregation [GO:0090330]; regulation of superoxide anion generation [GO:0032928]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; serotonin secretion [GO:0001820]; serotonin secretion by platelet [GO:0002554]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],B cell receptor complex [GO:0019815]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early phagosome [GO:0032009]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; T cell receptor complex [GO:0042101],ATP binding [GO:0005524]; integrin binding [GO:0005178]; interleukin-15 receptor binding [GO:0016170]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatase binding [GO:0019902]; phospholipase binding [GO:0043274]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; SH2 domain binding [GO:0042169]; Toll-like receptor binding [GO:0035325],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0006886; GO:0006913; GO:0007155; GO:0016192; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; intracellular protein transport; nucleocytoplasmic transport; cell adhesion; vesicle-mediated transport; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; defense response to other organism; catalytic activity, acting on a protein"
OG_01158,0.2462437521230718,FUN_004776-T1,Peve_00037750,Pocillopora_meandrina_HIv1___RNAseq.g6695.t1,three_way,65.822,FUN_004776-T1,Q2TBA3,MALT1_MOUSE,,Mucosa-associated lymphoid tissue lymphoma translocation protein 1 homolog (EC 3.4.22.-) (Paracaspase),Mus musculus (Mouse),29.1,709.0,3.5e-63,244.6,sp|Q2TBA3|MALT1_MOUSE Mucosa-associated lymphoid tissue lymphoma translocation protein 1 homolog OS=Mus musculus OX=10090 GN=Malt1 PE=1 SV=2,GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005829; GO:0006508; GO:0009620; GO:0019209; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043123; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0050870; GO:0051168; GO:0051603; GO:0061133; GO:0071222; GO:2000321,B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; cellular response to lipopolysaccharide [GO:0071222]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; nuclear export [GO:0051168]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852],CBM complex [GO:0032449]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; perinuclear region of cytoplasm [GO:0048471]; polkadots [GO:0002096],cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activator activity [GO:0061133]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; kinase activator activity [GO:0019209]; protease binding [GO:0002020]; ubiquitin-protein transferase activity [GO:0004842],GO:0002376; GO:0003824; GO:0005829; GO:0006913; GO:0016740; GO:0016787; GO:0030154; GO:0098542; GO:0098772; GO:0140096,"immune system process; catalytic activity; cytosol; nucleocytoplasmic transport; transferase activity; hydrolase activity; cell differentiation; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_01539,0.1435055723227245,FUN_006374-T1,Peve_00021373,Pocillopora_meandrina_HIv1___RNAseq.g20329.t1,three_way,50.056333333333335,,,,,,,,,,,,,,,,,
OG_01557,0.24836848093863,FUN_006438-T1,Peve_00038436,Pocillopora_meandrina_HIv1___RNAseq.g20295.t1,three_way,78.40966666666667,FUN_006438-T1,P29146,,,,,49.8,566.0,8.6e-155,548.9,sp|P29146|NECA_HYDVU PC3-like endoprotease variant A OS=Hydra vulgaris OX=6087 PE=2 SV=1,,,,,,
OG_01896,0.1878770917521929,FUN_007896-T1,Peve_00040697,Pocillopora_meandrina_HIv1___RNAseq.g30048.t1,three_way,77.057,FUN_007896-T1,Q96BY7,ATG2B_HUMAN,,Autophagy-related protein 2 homolog B,Homo sapiens (Human),38.0,2230.0,0.0,1251.9,sp|Q96BY7|ATG2B_HUMAN Autophagy-related protein 2 homolog B OS=Homo sapiens OX=9606 GN=ATG2B PE=1 SV=5,GO:0000045; GO:0000407; GO:0000422; GO:0000425; GO:0005783; GO:0005789; GO:0005811; GO:0032266; GO:0034045; GO:0034727; GO:0043231; GO:0043495; GO:0061709; GO:0061723; GO:0061908; GO:0120013,autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; glycophagy [GO:0061723]; pexophagy [GO:0000425]; piecemeal microautophagy of the nucleus [GO:0034727]; reticulophagy [GO:0061709],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; phagophore [GO:0061908]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045],lipid transfer activity [GO:0120013]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein-membrane adaptor activity [GO:0043495],GO:0005215; GO:0005783; GO:0005811; GO:0005975; GO:0006091; GO:0006914; GO:0008289; GO:0043226; GO:0060090,transporter activity; endoplasmic reticulum; lipid droplet; carbohydrate metabolic process; generation of precursor metabolites and energy; autophagy; lipid binding; organelle; molecular adaptor activity
OG_02175,0.3726321333612337,FUN_008524-T1,Peve_00027673,Pocillopora_meandrina_HIv1___RNAseq.g14752.t1,three_way,75.38833333333334,FUN_008524-T1,Q4R6K2,ZNT1_MACFA,,Proton-coupled zinc antiporter SLC30A1 (Solute carrier family 30 member 1),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),39.8,462.0,2.9e-73,277.3,sp|Q4R6K2|ZNT1_MACFA Proton-coupled zinc antiporter SLC30A1 OS=Macaca fascicularis OX=9541 GN=SLC30A1 PE=2 SV=1,GO:0000139; GO:0005789; GO:0005886; GO:0006882; GO:0010312; GO:0016323; GO:0019855; GO:0030659; GO:0031965; GO:0042742; GO:0046872; GO:0062111; GO:0140826; GO:0140882,defense response to bacterium [GO:0042742]; detoxification of zinc ion [GO:0010312]; intracellular zinc ion homeostasis [GO:0006882]; zinc export across plasma membrane [GO:0140882]; zinc ion import into organelle [GO:0062111],basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886],calcium channel inhibitor activity [GO:0019855]; metal ion binding [GO:0046872]; zinc:proton antiporter activity [GO:0140826],GO:0005215; GO:0005886; GO:0055085; GO:0098754; GO:0098772,transporter activity; plasma membrane; transmembrane transport; detoxification; molecular function regulator activity
OG_02620,0.1754337984250808,FUN_010763-T1,Peve_00008038,Pocillopora_meandrina_HIv1___RNAseq.g20924.t1,three_way,83.1185,FUN_010763-T1,O46382,,,,,58.7,1985.0,0.0,2090.5,sp|O46382|BIG1_BOVIN Brefeldin A-inhibited guanine nucleotide-exchange protein 1 OS=Bos taurus OX=9913 GN=ARFGEF1 PE=1 SV=1,,,,,,
OG_02822,0.3969782205659472,FUN_011810-T1,Peve_00020919,Pocillopora_meandrina_HIv1___RNAseq.g23237.t1,three_way,64.20366666666666,,,,,,,,,,,,,,,,,
OG_02877,0.3094768247995223,FUN_011927-T1,Peve_00039378,Pocillopora_meandrina_HIv1___RNAseq.g23328.t1,three_way,81.451,FUN_011927-T1,O60476,MA1A2_HUMAN,,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (EC 3.2.1.113) (Mannosidase alpha class 1A member 2) (Processing alpha-1,2-mannosidase IB) (Alpha-1,2-mannosidase IB)",Homo sapiens (Human),52.3,623.0,1e-183,644.8,"sp|O60476|MA1A2_HUMAN Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB OS=Homo sapiens OX=9606 GN=MAN1A2 PE=1 SV=1",GO:0000139; GO:0004571; GO:0005509; GO:0005783; GO:0005794; GO:0005975; GO:0006486; GO:0006491; GO:0007585; GO:0016020; GO:0036503; GO:0048286; GO:0070062; GO:1904381,carbohydrate metabolic process [GO:0005975]; ERAD pathway [GO:0036503]; Golgi apparatus mannose trimming [GO:1904381]; lung alveolus development [GO:0048286]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585],endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020],"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]",GO:0003824; GO:0005783; GO:0005794; GO:0005975; GO:0006486; GO:0009101; GO:0016787; GO:0030163; GO:0043226; GO:0048856; GO:1901135,catalytic activity; endoplasmic reticulum; Golgi apparatus; carbohydrate metabolic process; protein glycosylation; glycoprotein biosynthetic process; hydrolase activity; protein catabolic process; organelle; anatomical structure development; carbohydrate derivative metabolic process
OG_03178,0.2477889205435836,FUN_012624-T1,Peve_00040101,Pocillopora_meandrina_HIv1___RNAseq.g13730.t1,three_way,77.34,FUN_012624-T1,Q6AYY8,,,,,59.8,485.0,1.6e-169,597.4,sp|Q6AYY8|ACATN_RAT Acetyl-coenzyme A transporter 1 OS=Rattus norvegicus OX=10116 GN=Slc33a1 PE=2 SV=1,,,,,,
OG_03186,0.1905623792931957,FUN_012655-T1,Peve_00022124,Pocillopora_meandrina_HIv1___RNAseq.g22896.t1,three_way,83.30833333333334,FUN_012655-T1,B3TP03,CTR2_CHICK,,Cationic amino acid transporter 2 (CAT-2) (CAT2) (cCAT-2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2),Gallus gallus (Chicken),41.7,653.0,5.0000000000000004e-130,466.5,sp|B3TP03|CTR2_CHICK Cationic amino acid transporter 2 OS=Gallus gallus OX=9031 GN=SLC7A2 PE=2 SV=1,GO:0000064; GO:0005737; GO:0005794; GO:0005886; GO:0015189; GO:0031410; GO:0061459; GO:0097638; GO:0097639; GO:1903352,L-arginine import across plasma membrane [GO:0097638]; L-lysine import across plasma membrane [GO:0097639]; L-ornithine transmembrane transport [GO:1903352],cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886],L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064],GO:0005215; GO:0005794; GO:0005886; GO:0031410; GO:0043226; GO:0055085,transporter activity; Golgi apparatus; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport
OG_03298,0.3571330279830086,FUN_013365-T1,Peve_00001191,Pocillopora_meandrina_HIv1___RNAseq.g13342.t1,three_way,66.11066666666666,FUN_013365-T1,Q8IS64,,,,,46.9,685.0,1.8e-185,651.0,sp|Q8IS64|ECE_LOCMI Endothelin-converting enzyme homolog OS=Locusta migratoria OX=7004 PE=2 SV=1,,,,,,
OG_03368,0.3256652351135793,FUN_013613-T1,Peve_00002659,Pocillopora_meandrina_HIv1___RNAseq.g13533.t1,three_way,54.56916666666667,FUN_013613-T1,Q9P2K9,DISP3_HUMAN,,Protein dispatched homolog 3 (Patched domain-containing protein 2),Homo sapiens (Human),35.0,1203.0,7.2e-160,566.6,sp|Q9P2K9|DISP3_HUMAN Protein dispatched homolog 3 OS=Homo sapiens OX=9606 GN=DISP3 PE=1 SV=2,GO:0005737; GO:0005783; GO:0005789; GO:0007224; GO:0008203; GO:0016020; GO:0030154; GO:0030659; GO:0031965; GO:0032368; GO:0042632; GO:0045665; GO:0045834; GO:2000179,cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of lipid metabolic process [GO:0045834]; positive regulation of neural precursor cell proliferation [GO:2000179]; regulation of lipid transport [GO:0032368]; smoothened signaling pathway [GO:0007224],cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear membrane [GO:0031965],,GO:0005783; GO:0006629; GO:0030154; GO:0043226,endoplasmic reticulum; lipid metabolic process; cell differentiation; organelle
OG_03554,0.2381791621612735,FUN_014690-T1,Peve_00028116,Pocillopora_meandrina_HIv1___RNAseq.g22821.t1,three_way,83.69500000000001,FUN_014690-T1,Q8NFA0,UBP32_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12) (Deubiquitinating enzyme 32) (Renal carcinoma antigen NY-REN-60) (Ubiquitin thioesterase 32) (Ubiquitin-specific-processing protease 32),Homo sapiens (Human),44.8,1747.0,0.0,1401.3,sp|Q8NFA0|UBP32_HUMAN Ubiquitin carboxyl-terminal hydrolase 32 OS=Homo sapiens OX=9606 GN=USP32 PE=1 SV=1,GO:0000139; GO:0004843; GO:0005509; GO:0005794; GO:0005829; GO:0006508; GO:0016579; GO:1904263,positive regulation of TORC1 signaling [GO:1904263]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],calcium ion binding [GO:0005509]; cysteine-type deubiquitinase activity [GO:0004843],GO:0003824; GO:0005794; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; Golgi apparatus; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_03555,0.2448584277072435,FUN_014693-T1,Peve_00006835,Pocillopora_meandrina_HIv1___RNAseq.g22555.t1,three_way,67.01950000000001,FUN_014693-T1,Q8R3V6,,,,,37.2,309.0,2.4e-31,137.5,sp|Q8R3V6|CUED1_MOUSE CUE domain-containing protein 1 OS=Mus musculus OX=10090 GN=Cuedc1 PE=2 SV=2,,,,,,
OG_03806,0.2481059723187408,FUN_015193-T1,Peve_00013020,Pocillopora_meandrina_HIv1___RNAseq.g22296.t1,three_way,76.85266666666666,FUN_015193-T1,Q6PCX9,TRI37_MOUSE,,E3 ubiquitin-protein ligase TRIM37 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM37) (Tripartite motif-containing protein 37),Mus musculus (Mouse),79.4,447.0,4.6e-210,733.0,sp|Q6PCX9|TRI37_MOUSE E3 ubiquitin-protein ligase TRIM37 OS=Mus musculus OX=10090 GN=Trim37 PE=1 SV=1,GO:0000122; GO:0003682; GO:0003713; GO:0005164; GO:0005694; GO:0005737; GO:0005778; GO:0005829; GO:0006513; GO:0008270; GO:0016235; GO:0016558; GO:0031625; GO:0035098; GO:0042803; GO:0045814; GO:0046600; GO:0048471; GO:0050821; GO:0051865; GO:0061630; GO:0070842; GO:0140862,"aggresome assembly [GO:0070842]; negative regulation of centriole replication [GO:0046600]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; protein import into peroxisome matrix [GO:0016558]; protein monoubiquitination [GO:0006513]; protein stabilization [GO:0050821]",aggresome [GO:0016235]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778],chromatin binding [GO:0003682]; histone H2AK119 ubiquitin ligase activity [GO:0140862]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0003824; GO:0005694; GO:0005829; GO:0006325; GO:0006355; GO:0006886; GO:0007031; GO:0016740; GO:0043226; GO:0055085; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; chromosome; cytosol; chromatin organization; regulation of DNA-templated transcription; intracellular protein transport; peroxisome organization; transferase activity; organelle; transmembrane transport; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_04201,0.1227490264345013,FUN_016741-T1,Peve_00007364,Pocillopora_meandrina_HIv1___RNAseq.g236.t1,three_way,66.80833333333334,FUN_016741-T1,P84039,,,,,45.1,401.0,6.4e-103,375.9,sp|P84039|ENPP5_RAT Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 OS=Rattus norvegicus OX=10116 GN=Enpp5 PE=1 SV=2,,,,,,
OG_04303,0.2359851876900268,FUN_017881-T1,Peve_00001915,Pocillopora_meandrina_HIv1___RNAseq.g9851.t1,three_way,79.504,,,,,,,,,,,,,,,,,
OG_04326,0.280100487802413,FUN_017929-T1,Peve_00001599,Pocillopora_meandrina_HIv1___RNAseq.g283.t1,three_way,89.11483333333334,FUN_017929-T1,O75165,DJC13_HUMAN,,DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8),Homo sapiens (Human),66.3,1643.0,0.0,2240.3,sp|O75165|DJC13_HUMAN DnaJ homolog subfamily C member 13 OS=Homo sapiens OX=9606 GN=DNAJC13 PE=1 SV=5,GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0043231; GO:0070062; GO:1902954; GO:2000641,endosome organization [GO:0007032]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954],azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667],,GO:0005829; GO:0005886; GO:0016192; GO:0030154; GO:0043226,cytosol; plasma membrane; vesicle-mediated transport; cell differentiation; organelle
OG_04419,0.1895983540207941,FUN_018527-T1,Peve_00039208,Pocillopora_meandrina_HIv1___RNAseq.g9997.t1,three_way,66.57966666666667,,,,,,,,,,,,,,,,,
OG_04540,0.2057360005869393,FUN_022097-T1,Peve_00038679,Pocillopora_meandrina_HIv1___RNAseq.g4107.t1,three_way,79.26,FUN_022097-T1,A8MV24,,,,,47.5,141.0,3e-29,129.8,sp|A8MV24|SPMA1_HUMAN Sperm microtubule associated protein 1 OS=Homo sapiens OX=9606 GN=SPMAP1 PE=1 SV=1,,,,,,
OG_04563,0.4386081646997495,FUN_022204-T1,Peve_00041452,Pocillopora_meandrina_HIv1___TS.g22213.t2,three_way,62.89816666666666,FUN_022204-T1,Q92626,PXDN_HUMAN,,Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment],Homo sapiens (Human),28.5,270.0,2.3000000000000003e-22,109.4,sp|Q92626|PXDN_HUMAN Peroxidasin homolog OS=Homo sapiens OX=9606 GN=PXDN PE=1 SV=2,GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070062; GO:0070207; GO:0070831; GO:0071711; GO:0140825,angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],basement membrane [GO:0005604]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615],"extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; interleukin-1 receptor antagonist activity [GO:0005152]; lactoperoxidase activity [GO:0140825]; laminin-1 binding [GO:0043237]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxidase activity [GO:0004601]",GO:0002376; GO:0003824; GO:0005198; GO:0005576; GO:0005615; GO:0005783; GO:0007155; GO:0016209; GO:0016491; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0065003; GO:0098772,immune system process; catalytic activity; structural molecule activity; extracellular region; extracellular space; endoplasmic reticulum; cell adhesion; antioxidant activity; oxidoreductase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity
OG_04657,0.2250426929953289,FUN_022397-T1,Peve_00037595,Pocillopora_meandrina_HIv1___RNAseq.g9319.t1a,three_way,71.057,,,,,,,,,,,,,,,,,
OG_04990,0.2828390566262949,FUN_023120-T1,Peve_00021101,Pocillopora_meandrina_HIv1___RNAseq.g1691.t1,three_way,66.651,,,,,,,,,,,,,,,,,
OG_05016,0.248965549912173,FUN_023178-T1,Peve_00009977,Pocillopora_meandrina_HIv1___RNAseq.g659.t2,three_way,55.161,FUN_023178-T1,Q8WY21,SORC1_HUMAN,,VPS10 domain-containing receptor SorCS1 (hSorCS),Homo sapiens (Human),28.4,989.0,4.4e-95,351.3,sp|Q8WY21|SORC1_HUMAN VPS10 domain-containing receptor SorCS1 OS=Homo sapiens OX=9606 GN=SORCS1 PE=1 SV=3,GO:0005794; GO:0006892; GO:0007218; GO:0008188; GO:0016020,neuropeptide signaling pathway [GO:0007218]; post-Golgi vesicle-mediated transport [GO:0006892],Golgi apparatus [GO:0005794]; membrane [GO:0016020],neuropeptide receptor activity [GO:0008188],GO:0005794; GO:0016192; GO:0043226; GO:0060089,Golgi apparatus; vesicle-mediated transport; organelle; molecular transducer activity
OG_05020,0.2642843390999362,FUN_023183-T1,Peve_00009982,Pocillopora_meandrina_HIv1___RNAseq.g664.t1,three_way,89.54533333333333,FUN_023183-T1,Q7Z7H5,TMED4_HUMAN,,Transmembrane emp24 domain-containing protein 4 (Endoplasmic reticulum stress-response protein 25) (ERS25) (GMP25iso) (Putative NF-kappa-B-activating protein 156) (p24 family protein alpha-3) (p24alpha3),Homo sapiens (Human),75.1,213.0,5.4999999999999995e-92,338.6,sp|Q7Z7H5|TMED4_HUMAN Transmembrane emp24 domain-containing protein 4 OS=Homo sapiens OX=9606 GN=TMED4 PE=1 SV=1,GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0030134; GO:0043123,endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123],COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794],,GO:0005783; GO:0005794; GO:0006886; GO:0016192; GO:0031410; GO:0043226,endoplasmic reticulum; Golgi apparatus; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_06294,0.1847858930450023,FUN_028494-T1,Peve_00015135,Pocillopora_meandrina_HIv1___RNAseq.g16087.t1,three_way,73.79483333333333,FUN_028494-T1,Q96MW5,COG8_HUMAN,,Conserved oligomeric Golgi complex subunit 8 (COG complex subunit 8) (Component of oligomeric Golgi complex 8),Homo sapiens (Human),53.1,499.0,7.300000000000001e-145,515.8,sp|Q96MW5|COG8_HUMAN Conserved oligomeric Golgi complex subunit 8 OS=Homo sapiens OX=9606 GN=COG8 PE=1 SV=2,GO:0000139; GO:0000301; GO:0005794; GO:0006891; GO:0007030; GO:0015031; GO:0016020; GO:0017119; GO:0032588; GO:0070085,"glycosylation [GO:0070085]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]",Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; trans-Golgi network membrane [GO:0032588],,GO:0005794; GO:0016192; GO:0043226,Golgi apparatus; vesicle-mediated transport; organelle
OG_06302,0.2261520426900251,FUN_028508-T1,Peve_00008106,Pocillopora_meandrina_HIv1___RNAseq.g14114.t1,three_way,92.56366666666666,FUN_028508-T1,Q66HB3,IFT80_RAT,,Intraflagellar transport protein 80 homolog (WD repeat-containing protein 56),Rattus norvegicus (Rat),63.8,763.0,3.9e-310,1065.1,sp|Q66HB3|IFT80_RAT Intraflagellar transport protein 80 homolog OS=Rattus norvegicus OX=10116 GN=Ift80 PE=2 SV=1,GO:0001501; GO:0001503; GO:0001649; GO:0001958; GO:0002062; GO:0003417; GO:0003418; GO:0005737; GO:0005813; GO:0005929; GO:0006915; GO:0007163; GO:0007224; GO:0007249; GO:0008283; GO:0008543; GO:0009888; GO:0010467; GO:0010498; GO:0010839; GO:0016567; GO:0021510; GO:0030316; GO:0030992; GO:0033687; GO:0035264; GO:0035567; GO:0035630; GO:0036064; GO:0042476; GO:0043491; GO:0043616; GO:0044691; GO:0044782; GO:0048863; GO:0050821; GO:0051216; GO:0060173; GO:0060271; GO:0060348; GO:0060349; GO:0061975; GO:0071895; GO:0072089; GO:0097500; GO:0097731; GO:1902140; GO:1905515; GO:1990079; GO:2000051,apoptotic process [GO:0006915]; articular cartilage development [GO:0061975]; bone development [GO:0060348]; bone mineralization involved in bone maturation [GO:0035630]; bone morphogenesis [GO:0060349]; canonical NF-kappaB signal transduction [GO:0007249]; cartilage development [GO:0051216]; cartilage homeostasis [GO:1990079]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; endochondral ossification [GO:0001958]; establishment or maintenance of cell polarity [GO:0007163]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gene expression [GO:0010467]; growth plate cartilage chondrocyte differentiation [GO:0003418]; growth plate cartilage development [GO:0003417]; keratinocyte proliferation [GO:0043616]; limb development [GO:0060173]; multicellular organism growth [GO:0035264]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; non-canonical Wnt signaling pathway [GO:0035567]; non-motile cilium assembly [GO:1905515]; odontoblast differentiation [GO:0071895]; odontogenesis [GO:0042476]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; osteoclast differentiation [GO:0030316]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; proteasomal protein catabolic process [GO:0010498]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; receptor localization to non-motile cilium [GO:0097500]; response to inositol [GO:1902140]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; spinal cord development [GO:0021510]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; tissue development [GO:0009888]; tooth eruption [GO:0044691],9+0 non-motile cilium [GO:0097731]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992],,GO:0005815; GO:0005929; GO:0007163; GO:0012501; GO:0030154; GO:0030163; GO:0043226; GO:0044782; GO:0048856,microtubule organizing center; cilium; establishment or maintenance of cell polarity; programmed cell death; cell differentiation; protein catabolic process; organelle; cilium organization; anatomical structure development
OG_06457,0.215708325921653,FUN_029186-T1,Peve_00031210,Pocillopora_meandrina_HIv1___RNAseq.g25503.t1,three_way,70.64266666666667,FUN_029186-T1,Q8R4I1,ATX7_MOUSE,,Ataxin-7 (Spinocerebellar ataxia type 7 protein homolog),Mus musculus (Mouse),32.3,470.0,2.7e-26,122.5,sp|Q8R4I1|ATX7_MOUSE Ataxin-7 OS=Mus musculus OX=10090 GN=Atxn7 PE=1 SV=2,GO:0000124; GO:0003682; GO:0005634; GO:0005730; GO:0005737; GO:0005856; GO:0006282; GO:0006357; GO:0006366; GO:0016363; GO:0033276; GO:0043484; GO:0043569; GO:0045893; GO:0045944; GO:0048009,insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276],chromatin binding [GO:0003682],GO:0005634; GO:0005730; GO:0005856; GO:0006351; GO:0006355; GO:0043226,nucleus; nucleolus; cytoskeleton; DNA-templated transcription; regulation of DNA-templated transcription; organelle
OG_06485,0.2275361339012597,FUN_029259-T1,Peve_00024365,Pocillopora_meandrina_HIv1___RNAseq.g15031.t1b,three_way,71.01783333333333,FUN_029259-T1,Q6DN90,IQEC1_HUMAN,,IQ motif and SEC7 domain-containing protein 1 (ADP-ribosylation factors guanine nucleotide-exchange protein 100) (ADP-ribosylation factors guanine nucleotide-exchange protein 2) (Brefeldin-resistant Arf-GEF 2 protein) (BRAG2),Homo sapiens (Human),42.1,447.0,1.1e-74,283.1,sp|Q6DN90|IQEC1_HUMAN IQ motif and SEC7 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=IQSEC1 PE=1 SV=1,GO:0005085; GO:0005654; GO:0005813; GO:0005829; GO:0008021; GO:0008289; GO:0014069; GO:0016020; GO:0030036; GO:0032012; GO:0043231; GO:0051549; GO:0060996; GO:0120183,actin cytoskeleton organization [GO:0030036]; dendritic spine development [GO:0060996]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of keratinocyte migration [GO:0051549]; regulation of ARF protein signal transduction [GO:0032012],centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021],guanyl-nucleotide exchange factor activity [GO:0005085]; lipid binding [GO:0008289],GO:0005654; GO:0005815; GO:0005829; GO:0007010; GO:0008289; GO:0031410; GO:0043226; GO:0048856; GO:0098772,nucleoplasm; microtubule organizing center; cytosol; cytoskeleton organization; lipid binding; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity
OG_06807,0.2180583252716912,FUN_031706-T1,Peve_00022014,Pocillopora_meandrina_HIv1___TS.g24476.t1b,three_way,67.46533333333333,,,,,,,,,,,,,,,,,
OG_06952,0.2142525527668864,FUN_032065-T1,Peve_00024742,Pocillopora_meandrina_HIv1___RNAseq.g6040.t1,three_way,67.569,FUN_032065-T1,Q63HM2,,,,,39.0,1229.0,1.2e-228,795.0,sp|Q63HM2|PCX4_HUMAN Pecanex-like protein 4 OS=Homo sapiens OX=9606 GN=PCNX4 PE=1 SV=4,,,,,,
OG_06954,0.2284821240686608,FUN_032069-T1,Peve_00024738,Pocillopora_meandrina_HIv1___RNAseq.g6018.t1,three_way,64.7885,,,,,,,,,,,,,,,,,
OG_06971,0.2123159663803318,FUN_032104-T1,Peve_00011277,Pocillopora_meandrina_HIv1___RNAseq.g6000.t1,three_way,72.7205,FUN_032104-T1,Q8IWV8,UBR2_HUMAN,,E3 ubiquitin-protein ligase UBR2 (EC 2.3.2.27) (N-recognin-2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II),Homo sapiens (Human),42.3,1795.0,0.0,1350.1,sp|Q8IWV8|UBR2_HUMAN E3 ubiquitin-protein ligase UBR2 OS=Homo sapiens OX=9606 GN=UBR2 PE=1 SV=1,GO:0000151; GO:0000785; GO:0005634; GO:0005737; GO:0005829; GO:0007131; GO:0007140; GO:0007141; GO:0007283; GO:0008270; GO:0010526; GO:0016567; GO:0031507; GO:0032007; GO:0043161; GO:0050862; GO:0061630; GO:0070534; GO:0070728; GO:0071233; GO:0071596; GO:0141053,cellular response to L-leucine [GO:0071233]; heterochromatin formation [GO:0031507]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; positive regulation of T cell receptor signaling pathway [GO:0050862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; transposable element silencing [GO:0010526]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],histone H2A ubiquitin ligase activity [GO:0141053]; L-leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0006310; GO:0006325; GO:0016740; GO:0022414; GO:0030163; GO:0043226; GO:0140013; GO:0140096,"catalytic activity; nucleus; cytosol; DNA recombination; chromatin organization; transferase activity; reproductive process; protein catabolic process; organelle; meiotic nuclear division; catalytic activity, acting on a protein"
OG_07058,0.1706898571141438,FUN_032284-T1,Peve_00015547,Pocillopora_meandrina_HIv1___RNAseq.g24296.t2,three_way,84.13550000000001,FUN_032284-T1,A4IFE9,TM9S1_BOVIN,,Transmembrane 9 superfamily member 1,Bos taurus (Bovine),67.6,571.0,7.5e-229,794.7,sp|A4IFE9|TM9S1_BOVIN Transmembrane 9 superfamily member 1 OS=Bos taurus OX=9913 GN=TM9SF1 PE=2 SV=1,GO:0000421; GO:0005765; GO:0006914; GO:0016020; GO:0031410; GO:0072657,autophagy [GO:0006914]; protein localization to membrane [GO:0072657],autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],,GO:0006914; GO:0031410; GO:0043226,autophagy; cytoplasmic vesicle; organelle
OG_07312,0.2376649894633889,FUN_033703-T1,Peve_00027582,Pocillopora_meandrina_HIv1___RNAseq.g28765.t1,three_way,58.368833333333335,FUN_033703-T1,Q6GP15,,,,,32.4,463.0,5.3e-51,203.4,sp|Q6GP15|MED25_XENLA Mediator of RNA polymerase II transcription subunit 25 OS=Xenopus laevis OX=8355 GN=med25 PE=2 SV=1,,,,,,
OG_07701,0.2207999242281246,FUN_034835-T1,Peve_00007812,Pocillopora_meandrina_HIv1___RNAseq.g27183.t1,three_way,81.74166666666667,FUN_034835-T1,Q8N4L2,PP4P2_HUMAN,,"Type 2 phosphatidylinositol 4,5-bisphosphate 4-phosphatase (Type 2 PtdIns-4,5-P2 4-Ptase) (EC 3.1.3.78) (PtdIns-4,5-P2 4-Ptase II) (Transmembrane protein 55A)",Homo sapiens (Human),49.7,197.0,3.5e-48,193.4,"sp|Q8N4L2|PP4P2_HUMAN Type 2 phosphatidylinositol 4,5-bisphosphate 4-phosphatase OS=Homo sapiens OX=9606 GN=PIP4P2 PE=1 SV=1",GO:0005765; GO:0005886; GO:0030670; GO:0031902; GO:0034597; GO:0046856; GO:0050765,negative regulation of phagocytosis [GO:0050765]; phosphatidylinositol dephosphorylation [GO:0046856],late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886],"phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]",GO:0003824; GO:0005886; GO:0006629; GO:0016787,catalytic activity; plasma membrane; lipid metabolic process; hydrolase activity
OG_07714,0.4848455954731001,FUN_034867-T1,Peve_00005778,Pocillopora_meandrina_HIv1___RNAseq.g27146.t1,three_way,75.34383333333334,FUN_034867-T1,Q28193,FURIN_BOVIN,,Furin (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme) (PACE) (Trans Golgi network protease furin),Bos taurus (Bovine),49.8,616.0,5.7e-165,582.8,sp|Q28193|FURIN_BOVIN Furin OS=Bos taurus OX=9913 GN=FURIN PE=1 SV=1,GO:0000139; GO:0004252; GO:0005576; GO:0005802; GO:0005886; GO:0008201; GO:0010008; GO:0016486; GO:0046872; GO:0140447; GO:1904399,cytokine precursor processing [GO:0140447]; peptide hormone processing [GO:0016486],endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0005886; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; extracellular region; plasma membrane; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_07738,0.1895031813544913,FUN_034917-T1,Peve_00039135,Pocillopora_meandrina_HIv1___RNAseq.g12141.t1,three_way,71.13166666666666,,,,,,,,,,,,,,,,,
OG_08120,0.3747883356945479,FUN_035877-T1,Peve_00014421,Pocillopora_meandrina_HIv1___TS.g3329.t1b,three_way,54.79466666666666,FUN_035877-T1,A5PLK6,RGSL_HUMAN,,Regulator of G-protein signaling protein-like,Homo sapiens (Human),24.2,636.0,4.0999999999999997e-35,152.1,sp|A5PLK6|RGSL_HUMAN Regulator of G-protein signaling protein-like OS=Homo sapiens OX=9606 GN=RGSL1 PE=1 SV=1,GO:0016020,,membrane [GO:0016020],,,
OG_08273,0.2759260491600349,FUN_036188-T1,Peve_00023186,Pocillopora_meandrina_HIv1___RNAseq.g27373.t1,three_way,65.388,FUN_036188-T1,Q28DF1,,,,,31.8,422.0,7.4e-29,129.8,sp|Q28DF1|HERP2_XENTR Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 2 protein OS=Xenopus tropicalis OX=8364 GN=herpud2 PE=2 SV=1,,,,,,
OG_08310,0.3977629496623838,FUN_036335-T1,Peve_00031401,Pocillopora_meandrina_HIv1___RNAseq.g12101.t1,three_way,84.46183333333333,FUN_036335-T1,A0A0R4IC37,,,,,53.9,778.0,5.1e-235,815.5,sp|A0A0R4IC37|CPSF1_DANRE Cleavage and polyadenylation specificity factor subunit 1 OS=Danio rerio OX=7955 GN=cpsf1 PE=3 SV=2,,,,,,
OG_08597,0.31509789220869,FUN_037739-T1,Peve_00037364,Pocillopora_meandrina_HIv1___RNAseq.g1330.t1,three_way,79.21866666666666,FUN_037739-T1,Q8T293,,,,,40.8,353.0,1.5e-70,268.1,sp|Q8T293|DIAC2_DICDI Probable di-N-acetylchitobiase 2 OS=Dictyostelium discoideum OX=44689 GN=ctbs2 PE=3 SV=1,,,,,,
OG_08768,0.2937789203760517,FUN_038045-T1,Peve_00016980,Pocillopora_meandrina_HIv1___RNAseq.g843.t1,three_way,44.053,FUN_038045-T1,Q20176,NAS39_CAEEL,,Zinc metalloproteinase nas-39 (EC 3.4.24.-) (Nematode astacin 39),Caenorhabditis elegans,33.8,130.0,1.2e-13,79.7,sp|Q20176|NAS39_CAEEL Zinc metalloproteinase nas-39 OS=Caenorhabditis elegans OX=6239 GN=nas-39 PE=2 SV=4,GO:0004222; GO:0005509; GO:0005615; GO:0008237; GO:0008270; GO:0009953; GO:0016485,dorsal/ventral pattern formation [GO:0009953]; protein processing [GO:0016485],extracellular space [GO:0005615],calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; extracellular space; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_09179,0.2801146801840871,FUN_039859-T1,Peve_00014928,Pocillopora_meandrina_HIv1___TS.g1031.t1,three_way,39.94166666666667,,,,,,,,,,,,,,,,,
OG_09349,0.3306478948066063,FUN_040406-T1,Peve_00012177,Pocillopora_meandrina_HIv1___RNAseq.g10345.t1,three_way,54.08983333333333,FUN_040406-T1,Q8IUK5,,,,,36.4,382.0,1.3e-52,208.8,sp|Q8IUK5|PLDX1_HUMAN Plexin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PLXDC1 PE=1 SV=2,,,,,,
OG_09551,0.2402291366459966,FUN_041651-T1,Peve_00000466,Pocillopora_meandrina_HIv1___RNAseq.g14153.t1,three_way,42.71266666666666,,,,,,,,,,,,,,,,,
OG_09587,0.1926716551107728,FUN_041727-T2,Peve_00014621,Pocillopora_meandrina_HIv1___RNAseq.g15482.t1,three_way,56.12166666666667,FUN_041727-T2,A0A1L8EYB2,,,,,30.0,1104.0,5.600000000000002e-111,404.4,sp|A0A1L8EYB2|DAAF8_XENLA Dynein axonemal assembly factor 8 OS=Xenopus laevis OX=8355 GN=dnaaf8 PE=1 SV=1,,,,,,
OG_09681,0.2017044489495839,FUN_041906-T1,Peve_00007893,Pocillopora_meandrina_HIv1___RNAseq.g15370.t2,three_way,66.65266666666666,FUN_041906-T1,Q8TEB9,RHBL4_HUMAN,,Rhomboid-related protein 4 (RRP4) (EC 3.4.21.105) (Rhomboid domain-containing protein 1) (Rhomboid-like protein 4),Homo sapiens (Human),41.0,300.0,2.9e-57,224.2,sp|Q8TEB9|RHBL4_HUMAN Rhomboid-related protein 4 OS=Homo sapiens OX=9606 GN=RHBDD1 PE=1 SV=1,GO:0004175; GO:0004252; GO:0005783; GO:0005789; GO:0006915; GO:0010954; GO:0031293; GO:0031966; GO:0033619; GO:0034620; GO:0034644; GO:0036503; GO:0043066; GO:0043687; GO:0044322; GO:0045732; GO:0048515; GO:0051047; GO:1904211,"apoptotic process [GO:0006915]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; ERAD pathway [GO:0036503]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein processing [GO:0010954]; positive regulation of secretion [GO:0051047]; post-translational protein modification [GO:0043687]; spermatid differentiation [GO:0048515]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; mitochondrial membrane [GO:0031966],endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005783; GO:0012501; GO:0016787; GO:0022414; GO:0030154; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; programmed cell death; hydrolase activity; reproductive process; cell differentiation; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_09688,0.1341725686938635,FUN_041916-T1,Peve_00007878,Pocillopora_meandrina_HIv1___RNAseq.g15640.t1,three_way,85.84533333333333,FUN_041916-T1,Q03041,CNGA2_BOVIN,,Cyclic nucleotide-gated channel alpha-2 (CNG channel alpha-2) (CNG-2) (CNG2) (Cyclic nucleotide-gated channel alpha 3) (CNCalpha3) (CNGa3) (Olfactory cyclic nucleotide-gated channel subunit 1) (OCNC1),Bos taurus (Bovine),46.7,587.0,1.6999999999999998e-151,537.7,sp|Q03041|CNGA2_BOVIN Cyclic nucleotide-gated channel alpha-2 OS=Bos taurus OX=9913 GN=CNGA2 PE=1 SV=1,GO:0005216; GO:0005222; GO:0005223; GO:0005262; GO:0005516; GO:0005886; GO:0006813; GO:0006814; GO:0006816; GO:0007608; GO:0017071; GO:0030552; GO:0030553; GO:0044877; GO:0098655; GO:0098804,calcium ion transport [GO:0006816]; monoatomic cation transmembrane transport [GO:0098655]; potassium ion transport [GO:0006813]; sensory perception of smell [GO:0007608]; sodium ion transport [GO:0006814],intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; non-motile cilium membrane [GO:0098804]; plasma membrane [GO:0005886],calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellularly cAMP-activated cation channel activity [GO:0005222]; intracellularly cGMP-activated cation channel activity [GO:0005223]; monoatomic ion channel activity [GO:0005216]; protein-containing complex binding [GO:0044877],GO:0005215; GO:0005886; GO:0050877; GO:0055085,transporter activity; plasma membrane; nervous system process; transmembrane transport
OG_09934,0.2800403301531893,FUN_043092-T2,Peve_00038925,Pocillopora_meandrina_HIv1___RNAseq.g6998.t1,three_way,64.206,FUN_043092-T2,P55268,LAMB2_HUMAN,,Laminin subunit beta-2 (Laminin B1s chain) (Laminin-11 subunit beta) (Laminin-14 subunit beta) (Laminin-15 subunit beta) (Laminin-3 subunit beta) (Laminin-4 subunit beta) (Laminin-7 subunit beta) (Laminin-9 subunit beta) (S-laminin subunit beta) (S-LAM beta),Homo sapiens (Human),29.3,844.0,9.599999999999999e-61,238.0,sp|P55268|LAMB2_HUMAN Laminin subunit beta-2 OS=Homo sapiens OX=9606 GN=LAMB2 PE=1 SV=2,GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005608; GO:0005788; GO:0007155; GO:0007411; GO:0007528; GO:0007601; GO:0014002; GO:0014044; GO:0031594; GO:0043083; GO:0043260; GO:0045785; GO:0048677; GO:0051149; GO:0060041; GO:0062023; GO:0070062; GO:0072249; GO:0072274; GO:0098637; GO:0110011; GO:0150043; GO:2001046,astrocyte development [GO:0014002]; axon extension involved in regeneration [GO:0048677]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; metanephric glomerular basement membrane development [GO:0072274]; metanephric podocyte development [GO:0072249]; neuromuscular junction development [GO:0007528]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; retina development in camera-type eye [GO:0060041]; Schwann cell development [GO:0014044]; visual perception [GO:0007601],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; laminin-11 complex [GO:0043260]; laminin-3 complex [GO:0005608]; neuromuscular junction [GO:0031594]; protein complex involved in cell-matrix adhesion [GO:0098637]; synaptic cleft [GO:0043083],extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural constituent of synapse-associated extracellular matrix [GO:0150043]; structural molecule activity [GO:0005198],GO:0005198; GO:0005576; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0034330; GO:0043226; GO:0048856; GO:0050877,structural molecule activity; extracellular region; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; cell junction organization; organelle; anatomical structure development; nervous system process
OG_10033,0.3644166526752664,FUN_043290-T1,Peve_00016457,Pocillopora_meandrina_HIv1___RNAseq.g8864.t1,three_way,76.351,FUN_043290-T1,Q6GN42,CTL4_XENLA,,Choline transporter-like protein 4 (Solute carrier family 44 member 4),Xenopus laevis (African clawed frog),41.9,704.0,1e-147,525.4,sp|Q6GN42|CTL4_XENLA Choline transporter-like protein 4 OS=Xenopus laevis OX=8355 GN=slc44a4 PE=2 SV=1,GO:0005886; GO:0008292; GO:0015220; GO:0015297; GO:0015871; GO:0016324; GO:0030307; GO:0030974; GO:0032475; GO:0035675; GO:0061526; GO:0090422,acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]; thiamine pyrophosphate transmembrane transport [GO:0030974],apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886],antiporter activity [GO:0015297]; choline transmembrane transporter activity [GO:0015220]; thiamine pyrophosphate transmembrane transporter activity [GO:0090422],GO:0005215; GO:0005886; GO:0048856; GO:0055085,transporter activity; plasma membrane; anatomical structure development; transmembrane transport
OG_10121,0.571191454655092,FUN_043499-T1,Peve_00024907,Pocillopora_meandrina_HIv1___RNAseq.g7964.t1,three_way,56.86333333333334,FUN_043499-T1,P82279,CRUM1_HUMAN,,Protein crumbs homolog 1,Homo sapiens (Human),23.8,741.0,3.6e-48,196.4,sp|P82279|CRUM1_HUMAN Protein crumbs homolog 1 OS=Homo sapiens OX=9606 GN=CRB1 PE=1 SV=2,GO:0001750; GO:0001917; GO:0001974; GO:0005509; GO:0005576; GO:0005886; GO:0005902; GO:0005912; GO:0007009; GO:0007157; GO:0007163; GO:0007267; GO:0008104; GO:0010001; GO:0010467; GO:0010842; GO:0016324; GO:0032991; GO:0035003; GO:0035845; GO:0042462; GO:0043296; GO:0045197; GO:0045494; GO:0050908; GO:0060060; GO:0061159; GO:0071482; GO:0097386,blood vessel remodeling [GO:0001974]; cell-cell signaling [GO:0007267]; cellular response to light stimulus [GO:0071482]; detection of light stimulus involved in visual perception [GO:0050908]; establishment of bipolar cell polarity involved in cell morphogenesis [GO:0061159]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; plasma membrane organization [GO:0007009]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; protein localization [GO:0008104]; retina layer formation [GO:0010842],adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microvillus [GO:0005902]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003],calcium ion binding [GO:0005509],GO:0005576; GO:0005886; GO:0007155; GO:0007163; GO:0023052; GO:0030154; GO:0048856; GO:0061024,extracellular region; plasma membrane; cell adhesion; establishment or maintenance of cell polarity; signaling; cell differentiation; anatomical structure development; membrane organization
OG_10170,0.2067640470201137,FUN_043573-T1,Peve_00011698,Pocillopora_meandrina_HIv1___TS.g1621.t2,three_way,82.74133333333333,FUN_043573-T1,Q5ZIR1,,,,,52.2,364.0,7.2e-94,345.5,sp|Q5ZIR1|SHLB1_CHICK Endophilin-B1 OS=Gallus gallus OX=9031 GN=SH3GLB1 PE=2 SV=1,,,,,,
OG_10210,0.3033091324214486,FUN_043647-T1,Peve_00026900,Pocillopora_meandrina_HIv1___RNAseq.g7403.t1b,three_way,74.66133333333333,,,,,,,,,,,,,,,,,
